SIFI erhält positives CHMP-Gutachten für AKANTIOR® (Polihexanid 0,08 %) bei Acanthamoeba-Keratitis

Posted on by

ACI SANT’ANTONIO, Italien, 31. Mai 2024 /PRNewswire/ — SIFI gab bekannt, dass der Ausschuss für Humanarzneimittel (Committee for Medicinal Products for Human Use, CHMP) der Europäischen Arzneimittel-Agentur (European Medicines Agency, EMA) eine positive Stellungnahme abgegeben hat, in…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.